Navigation Links
HITSP Defines Overarching Set of Healthcare Security and Privacy Standards
Date:10/23/2007

may be addressed to Michelle Maas Deane, HITSP secretariat, at mmaasdeane@ansi.org. Industry experts interested in participating in the work of the HITSP and one or more of its technical committees may contact Jessica Kant, standards harmonization coordinator, Healthcare Information and Management Systems Society (HIMSS) at jkant@himss.org.

About HITSP

Operating under contract to the U.S. Department of Health and Human Services (HHS), the HITSP is administered by the American National Standards Institute (ANSI) in cooperation with strategic partners including the Healthcare Information and Management Systems Society (HIMSS), the Advanced Technology Institute (ATI) and Booz Allen Hamilton. The HITSP delivered its first set of formal recommendations (i.e., Interoperability Specifications) to the American Health Information Community (AHIC) in October 2006.

About ANSI

ANSI is a private non-profit organization whose mission is to enhance U.S. global competitiveness and the American quality of life by promoting, facilitating, and safeguarding the integrity of the voluntary standardization and conformity assessment system. The Institute currently administers five standards panels in the areas of healthcare information technology, biofuels, homeland security, nanotechnology, and identity theft prevention and identity management.


'/>"/>
SOURCE American National Standards Institute
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Healthcare sector is now a multi billion-dollar industry in India
2. Iodex goes to SmithKline Beecham consumer Healthcare
3. Healthcare Professionals Might Want To Rethink Their Dress Code
4. WHO report asks for improved healthcare for mother and child
5. New X-ray machine launched by GE Healthcare
6. India To March Ahead in The Global HealthCare Competition
7. Medical Fraternity Urged To Revamp Indian Healthcare
8. British Healthcare Mission Explores Partnership Possibilities With Indian Healthcare Sector
9. Need For Social Churning Emphasized In CMC Meet On ‘Leadership In Healthcare
10. LINK Applied Genomics Programme Promises To Revolutionize Healthcare Systems
11. India Can Manage World’s Healthcare Crisis By 202

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)... Hall, president and chief executive officer of th...he following statement regarding the inclusion of ...annual wellness for Medicare beneficiaries in &quo...uot; that was introduced last night: , ...09 -- Eric J. Hall, president and chief executive ...
(Date:11/20/2009)...0 /PRNewswire-FirstCall/ - NUCRYST Pharmaceuticals...hareholders will be held on Monday, December 21, 2...roval of two special resolutions. The first specia...of all or substantially all of the assets of NUCRY... asset purchase agreement dated November 10, 2009 ...
(Date:11/20/2009)...s and Congressmen in Competitive Re-election Battl... , Washington, DC (Vocus)...ning for re-election next year in races deemed to ... come to regret voting for House Speaker Nancy Pel...ing Zogby International/ O’Leary Report pol...
(Date:11/20/2009)...November 20 Cardio Vascu...SLMEDICAL.COM , a leading,developer of advanced ca...hat,the company,s Board of Directors has decided t...nd the Far East for its proprietary next-generatio...asty (PCTA) procedures. , Cardio Vascular...
(Date:11/20/2009)...ovember 20 in the Journal of the National Cancer ...es that often appear in news coverage of cancer re...he media and journals to help alleviate the proble...loshin, M.D., M.S., of Center for Medicine and the...y and Clinical Practice in New Hampshire, and Barn...
Breaking Medicine News(10 mins):Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2Health News:Promoting healthy skepticism in the news: Helping journalists get it right 2
...re Holdings,Inc. (Nasdaq: LNCR ) today announced ...nd Exchange Commission (the "SEC") a resale shelf ...08 on Form S-3 pursuant to the terms,of a registra...debentures due 2037 - Series A and $275 million,pr...
...on of KV,s Securities until February 15, ... KV Pharmaceutical Company,(NYSE: KVa/KVb) a fully...develops, manufactures, acquires and markets techn...request for a,trading extension through February 1...
...er in Next Generation Health Management ...ec. 28 It is a true win-win,situation. Crown Equi...rove,the health and productivity of its workforce....low health risk category,- an improvement of 12 pe...
...of restricted calorie intake for diabetics wanting...8 (HealthDay News) -- For the first time, the Amer...pport of low-carbohydrate diets for people with di...ractice recommendations. , The recommendations are...
...stCall/ - Transition Therapeutics Inc.,("Transitio...pleased to,announce that Mr. Carl Damiani has been... Since joining Transition in 2003, Mr. Damiani has...ding licensing and intellectual property strategie...
...(NYSE: MYL ),today announced that Mylan Pharmaceu....S. Food and Drug Administration (FDA) for its Abb...e Hydrochloride Tablets (OTC), 5 mg,and 10 mg., C...ng Sept. 30, 2007., This product will be shipped ...
Other Medicine News:Health News:Lincare Holdings Inc. Reports Intention to File Shelf Registration Statement 2Health News:KV Pharmaceutical Company Announces NYSE Listing Extension 2Health News:KV Pharmaceutical Company Announces NYSE Listing Extension 3Health News:Improving Employee Health While Reducing Costs - A Serious Business Strategy 2Health News:Improving Employee Health While Reducing Costs - A Serious Business Strategy 3Health News: Diabetes Group Backs Low-Carb Diets 2Health News:Transition Therapeutics Announces Appointment of Vice-President of Business Development 2
(Date:11/19/2009)...Newswire/ -- As the seasons change, another season...on preparing yourself. ,, Listen to this report...: ,, http://inr.mediaseed.tv/oneClip_C/?feed...nk is a division of The NewsMarket. Registered jo...and photos at http://www.thenewsmarket.com . ,...
(Date:11/19/2009)... 19 Mach 7 Technologies, a globa...age management solutions, and QStar Technologies h...- neutral archive solution through their common US...national leader in providing digital image distrib...try. Under the agreement, Data Distributing will ...
(Date:11/19/2009)...19 Impliant, Inc., a developer of ...pinal fusion surgery, announced today that it has ...as the Vice President of Clinical and Regulatory A...gi-bin/prnh/20080527/NETU060LOGO ) ,, Mr. Rol...rience in the spinal and medical device field to I...
Breaking Medicine Technology:Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 2Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 3Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 4Impliant Announces the Addition of Vice President of Clinical and Regulatory Affairs to Executive Management Team 2Impliant Announces the Addition of Vice President of Clinical and Regulatory Affairs to Executive Management Team 3Stories we tell about national trauma reflect our psychological well being 52964 1Stories we tell about national trauma reflect our psychological well being 52964 2Stories we tell about national trauma reflect our psychological well being 52964 3Microbes and their hosts exploring the complexity of symbiosis in DNA and cell biology 9396 1Microbes and their hosts exploring the complexity of symbiosis in DNA and cell biology 9396 2Wildfires set to increase 50 percent by 2050 9392 1Wildfires set to increase 50 percent by 2050 9392 2
... - INNOVIVE Pharmaceuticals,Inc. (OTCBB:IVPH) tod... INNO-406, a potent oral dual Bcr-Abl and Lyn-kina...tolerant chronic,myelogenous leukemia, will be pre...arch Annual Meeting. The meeting takes place April...in Los Angeles,California., Information related t...
...n Valopicitabine Combined,with an Investigational ...07 /PRNewswire-FirstCall/ --,Idenix Pharmaceutical... studies of the novel combination of valopicitabin...s(R)) in both treatment-naive,and treatment- exper...n of the hepatitis C virus (HCV). These data, as w...
Other Medicine Technology:Innovive Pharmaceuticals Announces Additional Data Presentations at,American Association for Cancer Research Annual Meeting 2Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 2Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 3Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 4Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 5Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 6Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 7
OSR Phenytoin Assay
Digoxin II
Emit 2000 (Convenience Pack) Digoxin Assay
Revised Drug Calibrator
Medicine Products: